MiniMed Group (NASDAQ:MMED) reported record fiscal 2026 revenue and outlined a slate of product launches it said will support faster growth in fiscal 2027, as management held the company’s first earnings call as a standalone public company following its March IPO.
Chief Executive Officer Que Dallara said MiniMed crossed the $3 billion annual revenue threshold for the first time in fiscal 2026, with organic revenue growth of 8%. The company ended the year with 659,000 global pump users, up 4% year over year.